Screening for primary aldosteronism on and off interfering medications-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Screening for primary aldosteronism on and off interfering medications

Published:2023-10-05 Issue:1 Volume:83 Page:178-187
ISSN:1559-0100
Container-title:Endocrine
language:en
Short-container-title:Endocrine

Author:

Li Xiaoyu,Liang Jiayu,Hu Jinbo,Ma Linqiang,Yang Jun,Zhang Aipin,Jing Ying,Song Ying,Yang Yi,Feng Zhengping,Du Zhipeng,Wang Yue,Luo Ting,He Wenwen,Shu Xiaoyu,Yang Shumin,Li Qifu^ORCID,Mei Mei,Luo Suxin,Liao Kangla,Zhang Yao,He Yunfeng,He Yihong,Xiao Ming,Peng Bin,

Funder

the National Natural Science Foundation of China

Joint Medical Research Project of Chongqing Science and Technology Commission & Chongqing Health and Family Planning Commission

National key research & development plan of China, major project of prevention and treatment for common diseases

The National Key Research and Development Project

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s12020-023-03520-6.pdf

Reference32 articles.

1. S. Monticone, J. Burrello, D. Tizzani, C. Bertello, A. Viola, F. Buffolo et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J. Am. Coll. Cardiol. 69, 1811–1820 (2017). https://doi.org/10.1016/j.jacc.2017.01.052

2. S.C. Käyser, T. Dekkers, H.J. Groenewoud, G.J. van der Wilt, J. Carel Bakx, M.C. van der Wel et al. Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis. J. Clin. Endocrinol. Metab. 101, 2826–35 (2016). https://doi.org/10.1210/jc.2016-1472

3. S. Monticone, F. D'ascenzo, C. Moretti, T.A. Williams, F. Veglio, F. Gaita et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 6, 41–50 (2018). https://doi.org/10.1016/s2213-8587(17)30319-4

4. Y. Jing, K. Liao, R. Li, S. Yang, Y. Song, W. He et al. Cardiovascular events and all-cause mortality in surgically or medically treated primary aldosteronism: a Meta-analysis. J. Renin Angiotensin Aldosterone Syst. 22, 14703203211003781 (2021). https://doi.org/10.1177/14703203211003781

5. V.C. Wu, S.M. Wang, C.H. Chang, Y.H. Hu, L.Y. Lin, Y.H. Lin et al. Long term outcome of Aldosteronism after target treatments. Sci. Rep. 6, 32103 (2016). https://doi.org/10.1038/srep32103

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long non-coding RNA HOTAIR: A biomarker and therapeutic target in urological tumors;Pathology - Research and Practice;2024-10

2. An eco-friendly convenient approach for the synthesis of guar gum integrated copper nanoparticles: Investigation of its catalytic activity in the C N Ullmann coupling reactions and study of its anti-human kidney cancer effects;Journal of Organometallic Chemistry;2024-10

3. Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-21

4. Green synthesis and cytotoxic activity of functionalized naphthyridine;Molecular Diversity;2024-08-08

5. A new route to the synthesis of 2-hydrazolyl-4-thiazolidinone hybrids, evaluation of α-glucosidase inhibitory activity and molecular modeling insights;Heliyon;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3